Expeditious and Efficient Synthesis of Benzoxazoles, Benzothiazoles, Benzimidazoles
3o: 1H NMR (CDCl3, 400 MHz) δ: 2.38 (s, 6H), 7.43
Am. Chem. Soc. 1979, 101, 6789.
(s, 2H), 7.94 (s, 1H), 8.22 (s, 1H).
8
9
(a) Gong, J. R.; Wan, L. J.; Lei, S. B.; Bai, C. L.; Zhang, X.
H.; Lee, S. T. J. Phys. Chem. B 2005, 109, 1675.
(b) Chen, T. R. J. Mol. Struct. 2005, 737, 35.
Rodembusch, F. S.; Buckup, T.; Segala, M.; Tavares, L.;
Correia, R. R. B.; Stefani, V. Chem. Phys. 2004, 305, 115.
1
3p: H NMR (CDCl3, 400 MHz) δ: 2.32 (s, 6H),
2.68 (s, 3H), 7.36 (s, 2H).
1
3q: H NMR (CDCl3, 400 MHz) δ: 0.86 (t, J=7.6
Hz, 3H), 1.37 (sext, J=7.6 Hz, 2H) 1.81 (quin, J=7.6
Hz, 2H), 2.33 (s, 6H), 2.92 (t, J=7.6 Hz, 2H), 7.33 (s,
2H), 10.49 (s, 1H).
10 Belmar, J.; Para, M.; Zuniga, C.; Perez, C.; Munoz, C. Liq.
Cryst. 1999, 26, 389.
3r: 1H NMR (CDCl3, 400 MHz) δ: 2.71 (s, 3H), 7.79
(d, J=8.4 Hz, 1H), 8.18 (d, J=8.4 Hz, 1H), 8.49 (s,
1H).
11 Katsura, Y.; Inoue, Y.; Tomishi, T.; Itoh, H.; Ishikawa, H.;
Takasugi, H. Chem. Pharm. Bull. 1992, 40, 2432.
12 Edwards, P. D.; Meyer, E. F.; Vijayalakshmi, J.; Tuthill, P.
A.; Andisik, D. A.; Gomes, B.; Strimpler, A. J. Am. Chem.
Soc. 1992, 114, 1854.
13 George, B.; Papadopoulos, E. P. J. Org. Chem. 1977, 42,
441.
14 Neef, G.; Eder, U.; Sauer, G. J. Org. Chem. 1981, 46, 2824.
15 (a) Hein, D. W.; Alheim, R. S.; Leavitt, J. J. J. Am. Chem.
Soc. 1957, 79, 427.
1
3s: H NMR (CDCl3, 400 MHz) δ: 0.88 (t, J=7.2
Hz, 6H), 1.43 (sext, J=7.2 Hz, 4H), 1.88 (quin, J=7.2
Hz, 4H), 3.03 (t, J=7.2 Hz, 4H), 7.62 (d, J=8.4 Hz,
4H), 8.16 (d, J=8.4 Hz, 4H), 8.48 (s, 2H) 11.04 (s, 2H).
3t: 1H NMR (CDCl3, 400 MHz) δ: 1.44 (t, J=7.6 Hz,
3H), 2.98 (q, J=7.6 Hz, 2H) 7.21—7.25 (m, 2H),
7.54—7.57 (m, 2H), 9.99 (s, 1H).
1
3u: H NMR (CDCl3, 400 MHz) δ: 0.91 (t, J=7.2
(b) Pool, W. O.; Harwood, H. J.; Ralston, A. W. J. Am.
Chem. Soc. 1937, 59, 178.
(c) Phillips, M. A. J. Chem. Soc. 1928, 2393.
(d) Raban, M.; Chang, H.; Craine, L.; Hortelano, E. J. Org.
Chem. 1985, 50, 2205.
(e) Lu, J.; Ge, H. G.; Bai, Y. J. Chin. J. Org. Chem. 2002, 22,
782.
(f) Bougrin, K.; Soufiaoui, M. Tetrahedron Lett. 1995, 36,
3683.
(g) Alcalde, E.; Dinarés, I.; Pérez-García, L.; Roca, T. Syn-
thesis 1992, 395.
(h) Dudd, L. M.; Venardou, E.; Garcia-Verdugo, E.; Licence,
P.; Blake, A. J.; Wilson, C.; Poliakoff, M. Green. Chem.
2003, 5, 187.
Hz, 3H), 1.38 (sext, J=7.2 Hz, 2H) 1.85 (quin, J=7.2
Hz, 2H), 2.93 (t, J=7.2 Hz, 2H), 7.18—7.22 (m, 2H),
7.52—7.55 (m, 2H), 9.02 (s, 1H).
1
3v: H NMR (CDCl3, 400 MHz) δ: 1.41 (t, J=7.6
Hz, 3H), 2.46 (s, 3H), 2.96 (q, J=7.6 Hz, 2H), 7.06 (d,
J=8.4 Hz, 1H), 7.32 (s, 1H), 7.46 (d, J=8.4 Hz, 1H),
8.42 (s, 1H).
5: 1H NMR (CDCl3, 400 MHz) δ: 0.98 (t, J=7.2 Hz,
6H), 1.43 (sext, J=7.2 Hz, 4H), 1.80 (quin, J=7.2 Hz,
4H), 2.87 (t, J=7.2 Hz, 4H), 7.47 (d, J=8.4 Hz, 2H),
7.54 (d, J=8.4 Hz, 2H), 7.69 (s, 2H).
Conclusions
(i) Lu, J.; Yang, B. Q.; Bai, Y. J. Synth. Commun. 2002, 32,
3703.
In conclusion, we have developed an expeditious,
novel and efficient method for the synthesis of ben-
zoxazole, benzothiazole, and benzimidazole derivatives
from o-substituted aminoaromatics with orthoesters us-
ing a catalytic amount of Ga(OTf)3 at room temperature.
The advantages of current protocol include high effi-
ciency, good substrate generality, environmental benign
catalyst, mild reaction conditions, and experimentally
operational ease, all of which make it a useful and at-
tractive strategy for the preparation of various ben-
zoxazole, benzothiazole, and benzimidazole derivatives
simply by changing different substrates.
16 Hein, D. W.; Alheim, R. J.; Leavitt, J. J. J. Am. Chem. Soc.
1957, 79, 427.
17 (a) Wang, L. M.; Sheng, J.; Tian, H.; Qian, C. T.; Höiijes, Jr.
E. L; Wagner, E. C. Synth. Commun. 2004, 34, 4265.
(b) Heravi, M. M.; Montazeri, N.; Rahmizadeh, M.;
Bakavoli, M.; Ghassemzadeh, M. J. Chem. Res (S) 2000,
584.
(c) Villemin, D.; Hammadi, M.; Martin, B. Synth. Commun.
1996, 26, 2895.
(d) Doise, M.; Dennin, F.; Blondeau, D.; Sliwa, H. Tetrahe-
dron Lett. 1990, 31, 1155.
(e) Jenkins, G. L.; Knevel, A. M.; Davis, C. S. J. Org. Chem.
1961, 26, 274.
References
(f) Zhang, Z. H.; Yin, L.; Wang, Y. M. Catal. Commun.
2007, 8, 1126.
(g) Zhang, Z. H.; Li, J. J.; Gao, Y. Z.; Liu, Y. H. J. Hetero-
cyclic. Chem. 2007, 44, 1509.
(h) Mohammadpoor-Baltork, I.; Khosropour, A. R.; Hojati,
S. F. Catal. Commun. 2007, 8, 1865.
(i) Mohammadpoor-Baltork, I.; Khosropour, A. R.; Hojati, S.
F. Monatsh. Chem. 2007, 138, 663.
1
2
Chen, C.; Chen, Y. J. Tetrahedron Lett. 2004, 45, 113.
Song, X.; Vig, B. S.; Lorenzi, P. L.; Drach, J. C.; Townsend,
L. B.; Amidon, G. L. J. Med. Chem. 2005, 48, 1274.
Yildiz-Oren, I.; Yalcin, I.; Aki-Sener, E.; Ucarturk, N. Eur. J.
Med. Chem. 2004, 39, 291.
Kumar, D.; Jacob, M. R.; Reynolds, M. B.; Kerwin, S. M.
Bioorg. Med. Chem. 2002, 10, 3997.
Benazzouz, A.; Boraud, T.; Dubédat, P.; Boireau, A.; Stutz-
mann, J. M.; Gross, C. Eur. J. Pharmacol. 1995, 284, 299.
Yamato, M. J. Pharm. Soc. Jpn. 1992, 112, 81.
3
4
5
(j) Heravi, M. M.; Baghernejad, B.; Oskooie, H. A. Chin. J.
Chem. 2009, 27, 379.
(k) Narsaiah, A. V.; Reddy, A. R.; Yadav, J. S. Synth.
6
7
Evans, D. A.; Sacks, C. E.; Kleschick, W. A.; Taber, T. R. J.
Chin. J. Chem. 2011, 29, 1739—1744
© 2011 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
1743